Related Experiment Videos
Probing protein binding sites by circular dichroism spectroscopy.
Ferenc Zsila1, Zsolt Bikádi, Ilona Fitos
1Department of Molecular Pharmacology, Institute of Chemistry, Chemical Research Centre, Budapest, POB 17, 1525, Hungary. zsferi@chemres.hu
Current Drug Discovery Technologies
|February 14, 2006
Summary
Circular dichroism (CD) spectroscopy reveals how drug molecules bind to human proteins. This technique uses induced chirality to provide insights into binding sites and drug interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Spectroscopy
Background:
- Drug-protein interactions are key to pharmacology and pharmacodynamics.
- Non-covalent interactions are central to these binding events.
- Spectroscopic methods are essential for studying these interactions.
Purpose of the Study:
- To review the application of Circular Dichroism (CD) spectroscopy in studying drug-protein binding.
- To highlight CD spectroscopy's sensitivity to ligand chirality induced by protein environments.
- To summarize recent findings on CD spectroscopy in drug-protein interaction research.
Main Methods:
- Utilizing Circular Dichroism (CD) spectroscopy to detect induced chirality in ligands.
- Analyzing extrinsic Cotton effects arising from ligand-protein interactions.
- Applying CD spectroscopy to gain qualitative and quantitative binding information.
Main Results:
- CD spectroscopy provides insights into ligand conformation and binding site interactions.
- Induced CD bands offer data on stereochemistry, binding site number, location, and nature.
- The technique is valuable for both optically active and inactive ligands.
Conclusions:
- Circular Dichroism (CD) spectroscopy is a powerful tool for characterizing drug-protein binding.
- It offers detailed information on the molecular basis of drug-target interactions.
- This review underscores the continued relevance and utility of CD spectroscopy in pharmaceutical research.